https://listovki.bg/aktivno/dinutuximab_beta
Dinutuximab beta — активна съставка — listovki.bg
Dinutuximab beta: 1 лекарствен продукт в България — форми, концентрации и притежатели на разрешение. Наличните документи са към конкретния вариант.
dinutuximab beta
https://synapse.patsnap.com/drug/796c984ca41746129ef405479c04560e
Dinutuximab beta - Drug Targets, Indications, Patents - Synapse
Dinutuximab beta: a GD2 inhibitors, ADCC, Complement dependent cytotoxicity (CDC) effects Drug, Initially developed by APEIRON Biologics GmbH, Now, its global...
dinutuximab betadrugtargetsindicationspatents
https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-2025/poster-session-2/dinutuximab-betaversus-naxitamab-in-the-treatment-of-relapsed-refractory-neuroblastoma--matching-adjusted-indirect-treatment-comparison-and-economic-evaluation-in-mexico
ISPOR - Dinutuximab BetaVersus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma -...
in theispordinutuximabnaxitamabtreatment